Skip to content
10-K

Annual Report

BIOLARGO, INC. BLGO

0001437749-25-010172

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 28, 2025 301.3M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$2.37M
Cash And Equivalents FY 2024 · Dec 31, 2023 $3.54M
Stockholders Equity FY 2024 · Dec 31, 2023 $6.84M
Current Liabilities FY 2024 · Dec 31, 2023 $2.71M
Total Liabilities FY 2024 · Dec 31, 2023 $4M
Current Assets FY 2024 · Dec 31, 2023 $6.36M
Total Assets FY 2024 · Dec 31, 2023 $8.21M
Eps Basic restated FY 2024 · Dec 31, 2023 −$0.01
Sga Expense FY 2024 · Dec 31, 2023 $8.06M
Rd Expense FY 2024 · Dec 31, 2023 $2.28M
Operating Income FY 2024 · Dec 31, 2023 −$4.58M
Gross Profit FY 2024 · Dec 31, 2023 $6.15M